ArticleCancer biology & therapy2018

Sorafenib inhibits caspase-1 expression through suppressing TLR4/stat3/SUMO1 pathway in hepatocellular carcinoma.

Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.